Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Boehringer Ingelheim
Harvard Business School
Medtronic
Dow
McKinsey

Last Updated: December 12, 2019

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR ABOBOTULINUMTOXINA

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

All Clinical Trials for abobotulinumtoxina

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00257660 Randomized, Placebo-Controlled Study of AbobotulinumtoxinA (Dysport®) for the Treatment of Cervical Dystonia Completed Ipsen Phase 3 2005-10-01 The aim of this study is to demonstrate the effectiveness and safety of 500 units of Dysport manufactured at a new manufacturing facility in Europe.
NCT00288509 Open-label Extension Study of AbobotulinumtoxinA (Dysport®) for the Treatment of Cervical Dystonia Completed Ipsen Phase 3 2006-02-01 The aim of this study is to assess longer term safety and effectiveness of Dysport®.
NCT00950664 A Study to Compare Dysport® and Botox® in the Treatment of Cervical Dystonia Completed Ipsen Phase 4 2009-08-01 1. to examine the non-inferiority of Dysport in the clinical efficacy and safety in comparison with Botox®, assuming a bioequivalence ratio of 2.5:1 units, in the treatment of Cervical dystonia. 2. double blind, randomised, multi center, crossover study
NCT00950664 A Study to Compare Dysport® and Botox® in the Treatment of Cervical Dystonia Completed Medical Research Collaborating Center, Seoul, Korea Phase 4 2009-08-01 1. to examine the non-inferiority of Dysport in the clinical efficacy and safety in comparison with Botox®, assuming a bioequivalence ratio of 2.5:1 units, in the treatment of Cervical dystonia. 2. double blind, randomised, multi center, crossover study
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for abobotulinumtoxina

Condition Name

Condition Name for abobotulinumtoxina
Intervention Trials
Cervical Dystonia 3
Urinary Incontinence 2
Pain 2
Overactive Bladder 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for abobotulinumtoxina
Intervention Trials
Dystonic Disorders 4
Dystonia 4
Muscle Spasticity 3
Torticollis 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for abobotulinumtoxina

Trials by Country

Trials by Country for abobotulinumtoxina
Location Trials
United States 64
Korea, Republic of 3
Belgium 2
Lebanon 2
Israel 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for abobotulinumtoxina
Location Trials
New York 5
Texas 4
Michigan 4
Florida 4
California 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for abobotulinumtoxina

Clinical Trial Phase

Clinical Trial Phase for abobotulinumtoxina
Clinical Trial Phase Trials
Phase 4 10
Phase 3 6
Phase 2/Phase 3 1
[disabled in preview] 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for abobotulinumtoxina
Clinical Trial Phase Trials
Not yet recruiting 8
Completed 6
Recruiting 5
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for abobotulinumtoxina

Sponsor Name

Sponsor Name for abobotulinumtoxina
Sponsor Trials
Ipsen 10
St Joseph University, Beirut, Lebanon 2
VA Greater Los Angeles Healthcare System 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for abobotulinumtoxina
Sponsor Trials
Other 18
Industry 13
U.S. Fed 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Harvard Business School
McKinsey
Moodys
Merck
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.